Bentham Science Logo

Contents

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Volume 2 - Number 1

The Evolving Therapy of Rheumatic Diseases, The Future is Now

, 2(1): 1 - 11

Yasser El-Miedany


DOI: 10.2174/1568008024606347




Hormone Mediation of Immune Responses in the Progression of Diabetes, Rheumatoid Arthritis and Periodontal Diseases

, 2(1): 13 - 25

M. Sorry


DOI: 10.2174/1568005310202010013




Clinical Pharmacology of Human Growth Hormone and its Secretagogues

, 2(1): 27 - 52

Allen W. Root and Michael J. Root


DOI: 10.2174/1568005310202010027




Cell Cycle Dysregulation During Hiv Infection: Perspectives of a Target Based Therapy

, 2(1): 53 - 62

Domenico Galati, Marialuisa Bocchino, Mirko Paiardini, Barbara Cervasi, Guido Silvestri and Giuseppe Piedimonte


DOI: 10.2174/1568005310202010053




Novel Peptides under Development for the Treatment of Type 1 and Type 2 Diabetes Mellitus

, 2(1): 63 - 82

Alain D. Baron, Dennis Kimm and Christian Weyer


DOI: 10.2174/1568005310202010063




Mucosal Immunity - Basic Principles, Ontogeny, Cystic Fibrosis and Mucosal Vaccination

, 2(1): 83 - 95

Z. Vancikova


DOI: 10.2174/1568005310202010083




Common Treatment of Polycystic Ovarian Syndrome and Major Depressive Disorder: Case Report and Review

, 2(1): 97 - 102

N. L. Rasgon, M. S. Carter, S. Elman, M. Bauer, M. Love and S. G. Korenman


DOI: 10.2174/1568005310202010097




Author Index To Volume 1

, 2(1): 103

Science Publishers Bentham


DOI: 10.2174/1568008024606338




Subject Index To Volume 1

, 2(1): 105

Science Publishers Bentham and Bentham Science Publishers


DOI: 10.2174/1568008024606275




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science